Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair... see more

TSXV:RP - Post Discussion

View:
Post by Ingiboy on Nov 04, 2022 10:33am

Update

I think most of us here are wondering why we have not received an update.  So many unanswered questions.  It is now past a year since the Shiseido Arbitration began with no idea of where this process is at.  We have also no idea of what is happening with the Dermal injector.  The shareholders have a right to know.
 What is the reason for this ? I am beginning to think they are holding back an update until after the close of the current Private Placement on Nov. 18th.  Why would they do that ?  I think the reason being is that the news is not all that great.  The Arbitration process could go on for months.  The Dermal Injector is simply not ready for submission for FDA Approval.  This doesn't mean the Arbitration Judgement will go against Relpicel and the Dermal injector is a bust.  It means that we thought that by the end of 2022 an Arbitration Judgement would have been rendered and the Dermal Injector would begin being marketed.
This obviously is not going to be the case as we come to the end of 2022.  There is no question that there will be an update at some point but I would not expect one until after Nov. 18th.
Comment by bluemoons20 on Nov 04, 2022 11:07am
Well givn past performance,  any  update will likely say  that  things  are progressing  and we are working  to resole the arbitration  and  get the  dermal  injector approved.  (while still collecting our salaries). I  would like to be  hopeful  but  after  years of  waiting  things  just seem to ...more  
Comment by toniZ1 on Nov 07, 2022 12:38am
idk if a year passed by since the abitriation has started. We only got notified that they engaged a law firm to start the process but not exactly by when it did take place.So maybe there are still wome weeks left...
Comment by BellEnd on Nov 07, 2022 11:39am
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities